These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5071652)

  • 21. Genetic basis of streptococcin A-FF22 production.
    Tagg JR; Wannamaker LW
    Antimicrob Agents Chemother; 1976 Aug; 10(2):299-306. PubMed ID: 984773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and properties of bacteriocins (mutacins) from Streptococcus mutans.
    Hamada S; Ooshima T
    Arch Oral Biol; 1975 Oct; 20(10):641-8. PubMed ID: 1059386
    [No Abstract]   [Full Text] [Related]  

  • 23. The elimination of bacteriocin production in the oral bacterium Streptococcus mutans.
    Fukushima H; Tsuboi Y; Fukushima S; Sagawa H
    Arch Oral Biol; 1980; 25(11-12):767-71. PubMed ID: 6943998
    [No Abstract]   [Full Text] [Related]  

  • 24. Bacteriocin production by Streptococcus milleri.
    Drucker DB; McKillop CM
    Can J Microbiol; 1982 Mar; 28(3):278-83. PubMed ID: 7083071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Group A streptococcal bacteriocin. Production, purification, and mode of action.
    Tagg JR; Dajani AS; Wannamaker LW; Gray ED
    J Exp Med; 1973 Nov; 138(5):1168-83. PubMed ID: 4744922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitor production by group-G streptococci of human and of animal origin.
    Tagg JR; Wong HK
    J Med Microbiol; 1983 Nov; 16(4):409-15. PubMed ID: 6644786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of Streptococcus sobrinus 6715 (g) in plaques by Streptococcus mutans 32K (c).
    Ikeda T; Kurita T; Hirasawa M
    J Oral Pathol; 1988 Nov; 17(9-10):471-4. PubMed ID: 3150434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on bacteriocinogeny of Streptococcus strains. I. Bacteriocinogeny of strains of the Streptococcus viridans group.
    Piatkowski K; Szropińska D
    Arch Immunol Ther Exp (Warsz); 1971; 19(2):137-45. PubMed ID: 4933384
    [No Abstract]   [Full Text] [Related]  

  • 29. Isolation of a Streptococcus mutans strain producing a novel bacteriocin.
    Hillman JD; Johnson KP; Yaphe BI
    Infect Immun; 1984 Apr; 44(1):141-4. PubMed ID: 6706403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriocin production by transformable group H streptococci.
    Schlegel R; Slade HD
    J Bacteriol; 1972 Nov; 112(2):824-9. PubMed ID: 5086661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin production.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):218-25. PubMed ID: 4552884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriocin types of Streptococcus mutans in human mouths.
    Rogers AH
    Arch Oral Biol; 1975 Dec; 20(12):853-8. PubMed ID: 1066101
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of mutacin administration on Streptococcus mutans-induced dental caries in rats.
    Ooshima T; Yasufuku Y; Izumitani A; Sumi N; Iwanami T
    Microbiol Immunol; 1985; 29(12):1163-73. PubMed ID: 3831717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Similarity of bacteriocin activity profiles of mutans streptococci within the family when the children acquire the strains after the age of 5.
    van Loveren C; Buijs JF; ten Cate JM
    Caries Res; 2000; 34(6):481-5. PubMed ID: 11093022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of Antilisterial Bacteriocins from Lactic Acid Bacteria in Dairy-Based Media: A Comparative Study.
    Ünlü G; Nielsen B; Ionita C
    Probiotics Antimicrob Proteins; 2015 Dec; 7(4):259-74. PubMed ID: 26341641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteriocin production and sensitivity among coaggregating and noncoaggregating oral streptococci.
    Tompkins GR; Peavey MA; Birchmeier KR; Tagg JR
    Oral Microbiol Immunol; 1997 Apr; 12(2):98-105. PubMed ID: 9227133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Typing of Proteus mirabilis by bacteriocin production and sensitivity as a possible epidemiological marker.
    Kusek JW; Herman LG
    J Clin Microbiol; 1980 Jul; 12(1):112-20. PubMed ID: 6999013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fingerprinting human oral streptococci by bacteriocin production and sensitivity.
    Kelstrup J; Richmond S; West C; Gibbons RJ
    Arch Oral Biol; 1970 Dec; 15(12):1109-16. PubMed ID: 5280118
    [No Abstract]   [Full Text] [Related]  

  • 39. Interactions between and within Streptococcus mutans and Streptococcus sobrinus isolated from humans harboring both species.
    Lindquist B; Emilson CG
    Scand J Dent Res; 1991 Dec; 99(6):498-504. PubMed ID: 1763286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteriocin of a group B streptococcus: partial purification and characterization.
    Tagg JR; Dajani AS; Wannamaker LW
    Antimicrob Agents Chemother; 1975 Jun; 7(6):764-72. PubMed ID: 1155919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.